{"paper_id":"b42c1776-4c9c-414c-be87-0832c0b6ebeb","body_text":"Natural Resources for\nHuman Health\nReview\nView Article Online\n \n \nReceived 25 August 2023\nRevised 02 October 2023\nAccepted 31 October 2023\nAvailable online 11 December\n2023\nEdited by Balamuralikrishnan\nBalasubramanian\nKEYWORDS:\nMedicinal plants\nPhytochemistry\nPhytochemical constituents\nGynecological disorder\nEndometriosis\nNatr Resour Human Health 2024; 4 (1): 75-88\nhttps://doi.org/10.53365/nrfhh/174668\neISSN: 2583-1194\nCopyright © 2024 Visagaa Publishing House\nIndian Medicinal Plants for the Management of\nEndometriosis: A Comprehensive Review on their\nphytopharmacology\nRustam Ekbbal 1, Aakash Kumar Jaiswal 2, Mansi Aggarwal 2,\nMhaveer Singh 3, Shadab Ali 1, Sayad Ahad Ali 1, Gaurav Gautam 1,*\n1IIMT College of Medical Sciences, IIMT University, O Pocket, Ganga Nagar, Meerut, Uttar\nPradesh 250001, India\n2School of Pharmaceutical Sciences, IIMT University, O Pocket, Ganga Nagar, Meerut, Uttar\nPradesh 250001, India\n3Pharmacy Academy, IFTM University, Moradabad, 244102, Uttar Pradesh, India\nABSTRACT: Endometriosis is a chronic gynecological disorder characterized by the aberrant\ngrowth of endometrial tissue outside the uterus, resulting in severe pain and infertility.\nConventional treatments often come with limitations and side effects, prompting a quest for\nalternative therapies. Medicinal plants, integral to traditional medicine systems, have emerged as\npotential solutions. This review delves into the phytopharmacology and chemistry of medicinal\nplants employed in endometriosis treatment. An exhaustive search revealed pertinent studies\nconcerning medicinal plant use in endometriosis treatment. These studies were scrutinized for\ntheir phytopharmacological attributes and active chemical constituents. Numerous medicinal\nplants exhibited anti-inflammatory, analgesic, antioxidant, immunomodulatory, and hormone-\nregulating properties, pivotal in endometriosis management. Mechanisms encompassed the\nsuppression of inflammatory mediators, modulation of estrogen signaling, mitigation of oxidative\nstress, and enhancement of immune function. Furthermore, key chemical constituents\nresponsible for these effects were pinpointed and classified into classes such as flavonoids,\nterpenoids, alkaloids, and phenolic compounds. These bioactive agents elicited their actions\nvia diverse molecular targets, including cyclooxygenase enzymes, estrogen receptors, nuclear\nfactor-kappa B, and reactive oxygen species. The findings underscore the potential of medicinal\nplants as adjunct therapies for endometriosis. Nonetheless, additional preclinical and clinical\ninvestigations are imperative to substantiate their efficacy, safety, and optimal dosing. Grasping\nthe phytopharmacology and chemistry of medicinal plants in endometriosis treatment lays\nthe groundwork for novel therapeutic agent development, spotlighting the capacity of natural\nproducts to combat this intricate gynecological ailment.\n1. INTRODUCTION\nEndometriosis characterized by overgrowing endometrium\ntissue outside the uterus, on ovaries, fallopian tubes, and\nother pelvic organs. In rare cases, it may even spread\nbeyond the pelvic region ( Koninckx et al. , 2021; Smolarz et\nal., 2021). Endometriosis is often a painful condition that\nprimarily affects women of reproductive age. The exact cause of\nendometriosis is unknown, but retrograde menstruation (when\nmenstrual blood flows back through the fallopian tubes), genetic\nfactors, hormonal imbalances, and immune system disorders\nhave been characterized for induction of the endometriosis.\nPainful periods, pain during bowel movements or urination,\npain during sexual intercourse, heavy or irregular menstrual\nbleeding, fatigue, and infertility are the major symptoms of\nthe endometriosis ( Koninckx et al. , 2021; Maulitz et al. ,\n2022). However, it’s important to note that the severity of\nsymptoms can vary greatly among individuals. Endometriosis\nis diagnosed by detailed physical examination, medical history,\nultrasound, and sometimes laparoscopic surgery and biopsy\nof the endometrial tissue. Laparoscopy is currently the most\naccurate method for diagnosing endometriosis. Hormonal\ntherapies (such as birth control pills or gonadotropin-releasing\nhormone agonists), and surgery to remove or excise the\nendometrial implants are the most promising option for\nendometriosis ( Agarwal et al. , 2019; Smolarz et al. , 2021).\n* Corresponding author.\nE-mail address: gautamgaurav878@gmail.com (Gaurav Gautam)\nThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).\n\n\nEkbbal et al View Article Online\nIn cases where fertility is a concern, assisted reproductive\ntechnologies or surgery to address anatomical abnormalities\nmay be considered. It’s important for individuals experiencing\nsymptoms suggestive of endometriosis to consult with a\nhealthcare professional, preferably a gynecologist or a specialist\nin reproductive health ( Agarwal et al. , 2019).\nMedicinal plants have been used for centuries in various\ntraditional systems of medicine, and they continue to play a\ncrucial role in modern healthcare. There are several approaches\nthat makes medicinal plants enriched for treating various disease\nincluding natural source of therapeutic compounds, Medicinal\nplants contain a diversity of phytoconstituents such as alkaloids,\nflavonoids, terpenoids, and phenolics, which possess medicinal\nproperties ( Ahmad et al. , 2021; Gaurav et al. , 2023; Gautam\net al. , 2021). These natural compounds can be used as a\nsource of drugs or serve as lead compounds for the development\nof synthetic drugs. Medicinal plants offer a vast reservoir\nof bioactive molecules that can be utilized for the treatment\nof various diseases ( Gaurav et al. , 2022; Zahiruddin et al. ,\n2021). T raditional Medicine and Cultural Heritage: Medicinal\nplants are integral to traditional systems of medicine, such\nas Ayurveda, T raditional Chinese Medicine, and Indigenous\nhealing practices. They form an important part of cultural\nheritage and traditional knowledge systems ( Basist et al. , 2022;\nM.U. Khan, Gaurav, et al. , 2022). Many communities rely\non medicinal plants for their healthcare needs, and their\npreservation and utilization contribute to the maintenance of\ncultural diversity and traditional healing practices. Medicinal\nplants can provide accessible and affordable healthcare options,\nparticularly in regions where modern healthcare infrastructure\nis limited or expensive. Local communities often have direct\naccess to medicinal plants and can use them for self-care and\ntreatment of common ailments ( Gaurav et al. , 2022; A. Khan\net al. , 2021; M.U. Khan, Gautam, et al. , 2022). Medicinal\nplants can serve as a cost-effective alternative or complement\nto conventional medicine, especially in resource-constrained\nsettings. Medicinal plants have been a valuable source of drugs\nand have provided the foundation for numerous pharmaceutical\ncompounds (Gautam, 2022; Ibrahim et al., 2021).\nMany modern drugs have been derived from plant com-\npounds or inspired by them. Active compounds isolated from\nmedicinal plants have led to the development of drugs used\nto treat various conditions, including cancer, cardiovascular\ndiseases, infections, and more. Medicinal plants play a\nsignificant role in biodiversity conservation. The preservation\nof diverse plant species and their ecosystems is crucial for\nmaintaining a sustainable supply of medicinal resources (Gaurav\net al. , 2022; Z. Gaurav et al. , 2020). Conserving medicinal\nplants not only protects their potential therapeutic benefits but\nalso helps to preserve ecosystems, protect endangered species,\nand maintain ecological balance. T raditional Knowledge\nand Scientific Research: T raditional knowledge related to\nmedicinal plants holds immense value and can guide scientific\nresearch ( Gaurav et al. , 2023; Zahiruddin et al. , 2021).\nBy studying the traditional uses and practices associated\nwith medicinal plants, researchers can discover new bioactive\ncompounds, validate traditional claims, and explore novel\ntherapeutic avenues. Integrating traditional knowledge with\nscientific research promotes a holistic and comprehensive\nunderstanding of medicinal plants. It’s important to note\nthat while medicinal plants offer significant potential, proper\nresearch, quality control, and regulatory measures are necessary\nto ensure their safety, efficacy, and sustainable use ( Gautam et\nal., 2023).\n2. REVIEW FINDING\n2.1. Phytochemicals reported for management of endometriosis\nVarious natural chemical constituents explored for their\ntherapeutic effects in managing the symptoms and reducing\ninflammation associated with the condition. Among different\nphytoconstituents, multi-targeted therapeutic effect has been\nexplored (Qi et al. , 2021; Sheikholeslami et al., 2021).\nCurcumin is a natural constituent sourced by turmeric\nor Curcuma longa; a spice used in Indian cuisine. It has\nantioxidant and anti-inflammatory properties that may help\nreduce pain and inflammation associated with endometriosis.\nIt exhibits strong anti-inflammatory properties by inhibiting\nvarious inflammatory mediators, such as cytokines such as\ntumor necrosis factor-alpha (TNF- \u000b), interleukin-1\f (IL-1\f),\nand interleukin-6 (IL-6) and enzymes (such as cyclooxygenase-\n2 and 5-lipoxygenase). By reducing inflammation, curcumin\nmay help to alleviate pain and reduce the inflammatory\nenvironment associated with endometriosis. It acts as a potent\nantioxidant and can scavenge free radicals and reduce oxidative\nstress. Oxidative stress is implicated in the pathogenesis of\nendometriosis, and curcumin’s antioxidant activity may help to\ncounteract cellular damage, reduce inflammation, and promote\noverall tissue health ( Arablou & Kolahdouz-Mohammadi ,\n2018; Vallée & Lecarpentier, 2020).\nCurcumin has been reported to modulate estrogen receptor\nsignaling. It can act as a selective estrogen receptor modu-\nlator (SERM), exhibiting both estrogenic and anti-estrogenic\neffects depending on the context. By modulating estrogen\nreceptors, curcumin may help regulate estrogenic activity in\nendometriotic lesions, potentially inhibiting their growth and\nreducing associated symptoms. Curcumin has been found\nto inhibit angiogenesis, the process of new blood vessel\nformation (Arablou & Kolahdouz-Mohammadi, 2018; Clower\net al., 2022; Vallée & Lecarpentier, 2020). Angiogenesis plays\na critical role in the growth and survival of endometriotic\nlesions. By inhibiting angiogenesis, curcumin may help to\nlimit the blood supply to endometriotic lesions, impeding their\ngrowth and progression. It also influences various signaling\npathways involved in cell proliferation, survival, and invasion.\nIt can inhibit the activation of pathways such as mitogen-\nactivated protein kinase (MAPK), nuclear factor-kappa B (NF-\n\u0014B), and phosphatidylinositol 3-kinase (PI3K)/Akt, which are\nimplicated in endometriosis pathogenesis. By interfering with\nthese signaling pathways, curcumin may help regulate cellular\nprocesses and inhibit the growth and invasiveness of endometri-\nN a t u r a l R e s o u r c e s f o r H u m a n H e a l t h 2024, 4, 75–88 | 76\n\nEkbbal et al View Article Online\notic lesions ( Gautam et al. , 2021; Kuttan et al. , 1985). It has\nimmunomodulatory effects and can regulate immune cell func-\ntion and cytokine production. It regulates anti-inflammatory\nand pro-inflammatory cytokines, leading to a shift towards\nan anti-inflammatory environment. By modulating immune\nresponses, curcumin may help reduce immune dysregulation\nand inflammation associated with endometriosis. ( Chowdhury\net al., 2019; S.Y. Kim et al., 2019).\nOmega-3 fatty acids, particularly eicosapentaenoic acid\n(EPA) as well as docosahexaenoic acid (DHA), are found in\ndifferent fatty fish like mackerel, salmon, and sardines. They\npossess anti-inflammatory properties and reduces symptoms\nsuch as pain as well as inflammation (Akyol et al., 2016; Khanaki\net al. , 2012; T .H. Kim et al. , 2013). Resveratrol is a natural\ncompound found in grapes, red wine, and berries. It has anti-\ninflammatory and antioxidant properties that may help manage\ninflammation associated with endometriosis. N-acetylcysteine\n(NAC) is a compound that acts as a precursor to glutathione,\na powerful antioxidant in the body. It has been studied for its\npotential benefits in reducing oxidative stress and inflammation\nin endometriosis Bahat et al. (2022).\nQuercetin is a flavonoid found in various fruits, vegetables,\nand herbs. It reduce inflammation and pain associated with\nendometriosis. Anti-inflammatory activity: Quercetin exerts\npotent anti-inflammatory effects by inhibiting the production\nand release of chemokines, pro-inflammatory cytokines, and\ninflammatory mediators. It regulates expression of transcription\nfactors, such as nuclear factor-kappa B (NF- \u0014B), that centrally\ntrigger inflammatory response. By reducing inflammation,\nquercetin helps to alleviate pain and suppress the growth\nand progression of endometriotic lesions ( Bahat et al. , 2022).\nQuercetin possesses strong antioxidant activity, which helps\nto counteract oxidative stress in endometriosis. It scavenges\nROS and inhibits lipid peroxidation, thereby reducing cellular\ndamage and oxidative stress-induced inflammation. By\nprotecting cells from oxidative damage, quercetin supports the\nmaintenance of normal cellular function and helps to mitigate\nthe pathological changes associated with endometriosis ( Basist\net al., 2022; Gautam et al., 2021).\nQuercetin act as anti-angiogenesis, via interfering in the\nsignaling pathways involved in angiogenesis and reduces the\nproduction of pro-angiogenic factors. This anti-angiogenic\nactivity of quercetin can help to impair the blood supply to\nendometriotic lesions, inhibiting their growth and develop-\nment. Quercetin exhibits estrogenic and anti-estrogenic effects,\ndepending on the hormonal milieu. It can bind to estrogen\nreceptors and modulate estrogen signaling pathways, which\nmay help to counteract the proliferative effects of estrogen on\nendometrial and endometriotic tissues. By regulating hormonal\nbalance, quercetin contributes to the control of endometriosis\nprogression. Induction of apoptosis: Quercetin has also been\nfound to induce apoptosis, or programmed cell death, in\nendometrial and endometriotic cells. This pro-apoptotic effect\nhelps to promote the regression and reduction of endometriotic\nlesions (Cao et al., 2014; Lin et al., 2022).\nQuercetin has immunomodulatory effects, influencing\nimmune cell function and cytokine production. By modulating\nimmune responses, quercetin helps to reduce immune\ndysregulation and inflammation associated with endometriosis.\nit is reported that quercetin exert epigenetic modifications,\nparticularly DNA methylation and histone acetylation. These\nmodifications can regulate gene expression patterns, including\nthose involved in inflammatory pathways, cell proliferation, and\nangiogenesis. By influencing epigenetic mechanisms, quercetin\nmay contribute to the modulation of key genes involved in\nendometriosis development and progression ( Abramiuk et al. ,\n2022; Jafarinia et al., 2020; Nathiya et al., 2014; Scheerer et al.,\n2016).\nEndometriosis can be connected with the expansion of\nfibrotic tissue, which contributes to the formation of adhesions\nand scarring. Quercetin has been shown to have anti-\nfibrotic properties by inhibiting the production of collagen,\nand reducing the deposition of fibrotic tissue. This action\nhelps to prevent the formation of adhesions and improve\ntissue remodeling in endometriosis (Matsuzaki & Darcha, 2015;\nSheikholeslami et al. , 2021). It can inhibit the activation\nof pathways such as PI3K/Akt, MAPK/ERK, and Wnt/ \f-\ncatenin, which are implicated in endometriosis pathogenesis.\nBy interfering with these signaling pathways, quercetin helps\nto regulate cellular processes and inhibit the growth and\ninvasiveness of endometriotic lesions. It has also been\nreported to possess analgesic properties, helping to alleviate\npain associated with endometriosis. It can modulate pain\nsignaling pathways, including the inhibition of inflammatory\nmediators and the regulation of pain receptors. By reducing\npain perception, quercetin contributes to the improvement of\nquality of life in individuals with endometriosis ( Chanjitwiriya\net al., 2020; Seo et al., 2015).\nBromelain is an enzyme found in pineapple stems exhibits\nanti-inflammatory properties and may help alleviate pain and\ninflammation in endometriosis. It exhibits significant anti-\ninflammatory properties by modulating the production and\nactivity of various inflammatory mediators, such as cytokines\nand chemokines. It can inhibit the synthesis of prostaglandins\nand leukotrienes, which are involved in the inflammatory\nresponse. By reducing inflammation, bromelain may help\nto alleviate pain and reduce the inflammatory environment\nassociated with endometriosis. it has been shown to possess\nfibrinolytic properties, meaning it can break down fibrin, a\nprotein involved in blood clot formation. In endometriosis,\nthe presence of excessive fibrin can contribute to the formation\nof adhesions and scar tissue ( Agostinis et al. , 2015; Lete et al. ,\n2018). Bromelain’s fibrinolytic activity may help to dissolve\nthese adhesions and improve tissue remodeling, potentially\nreducing pain and improving fertility outcomes. It has also\nbeen reported to exhibit immunomodulatory effects that can\ninfluence immune cell function and regulate the immune\nresponse. It can modulate the production of cytokines and\nchemokines, thereby regulating immune cell recruitment and\nactivation. By modulating the immune system, bromelain may\nN a t u r a l R e s o u r c e s f o r H u m a n H e a l t h 2024, 4, 75–88 | 77\n\nEkbbal et al View Article Online\nhelp to reduce immune dysregulation and the inflammatory\nresponse associated with endometriosis ( Lete et al., 2018; T ucci\net al., 2018).\nBromelain possesses antioxidant properties and can scavenge\nROS and inhibit lipid peroxidation. Oxidative stress triggers\nthe pathogenesis of endometriosis, and the antioxidant activity\nof bromelain may help to mitigate cellular damage and\ninflammation associated with oxidative stress. It also aids in\ndigestion by breaking down proteins. Although the direct\nimpact of bromelain’s digestive properties on endometriosis\nis unclear, improved digestion and nutrient absorption may\nsupport overall health and well-being, potentially influencing\nthe progression and symptoms of endometriosis ( Lete et al. ,\n2018; Saptarini et al., 2019; T ucci et al., 2018).\nMoreover, magnesium containing products that plays a\nvital role in various bodily functions. It has been suggested\nthat magnesium deficiency may contribute to increased pain\nsensitivity in endometriosis. Supplementing with magnesium\nmay help reduce pain symptoms ( Harris et al. , 2013).\nVitamin D is an essential nutrient that plays a role in\nimmune function and inflammation regulation. Some studies\nhave found an association between vitamin D deficiency\nand increased risk of endometriosis. Maintaining adequate\nvitamin D levels may be beneficial in managing the condition.\nMyo-inositol is a naturally occurring sugar alcohol that has\nbeen studied for its potential benefits in polycystic ovary\nsyndrome (PCOS) and endometriosis. It may help improve\nhormone balance and reduce symptoms such as pain and\nirregular periods. Vitamin E is a fat-soluble vitamin with\nantioxidant properties. Some studies suggest that vitamin\nE supplementation may help reduce pain and inflammation\nassociated with endometriosis. It is often recommended to be\ntaken alongside other treatments (Bahat et al., 2022; Barnard et\nal., 2023; Miyashita et al., 2016).\nCannabidiol (CBD) found in cannabis plant, is a non-\npsychoactive compound exhibits anti-inflammatory and pain-\nrelieving properties. Some individuals with endometriosis\nhave reported finding relief from symptoms through the use\nof CBD products. However, more research is needed to\nestablish its efficacy and safety for endometriosis specifically.\nZinc is a mineral involved in various physiological processes,\nincluding immune function and hormone regulation. Some\nstudies suggest that zinc deficiency may be associated with\nendometriosis. Supplementing with zinc may help support\nimmune function and reduce inflammation. Endometriosis is\nassociated with increased production of prostaglandins, which\nare hormone-like compounds that contribute to inflammation\nand pain. Evening primrose oil and borage oil contains\ngamma-linolenic acid (GLA) and omega-6 fatty acid inhibit\nthe production of inflammatory prostaglandins and provide\nrelief from symptoms ( Mistry et al. , 2022; NCT04527003,\n2020; Rbr-6ryrpjs, 2021). Pelargonidin is a natural pigment\nfound in various fruits and vegetables, such as strawberries and\nred peppers. It possesses antioxidant and anti-inflammatory\nproperties, and some studies suggest that it may help reduce\nthe growth of endometrial tissue and alleviate symptoms ( Liu\net al. , 2020; Lodhi & Kori , 2021). Lycopene is a naturally\noccurring pigment found in tomatoes, watermelon, and other\nfruits ( Campos et al. , 2017; Van Steenwijk et al. , 2020). It\npossesses antioxidant and anti-inflammatory properties and may\nhelp reduce the growth of endometrial tissue and alleviate\nsymptoms.\nBerberine is a naturally alkaloid found in various plants,\nsuch as Tinospora cordifolia, Berberis aristate, Gymnema sylvestre.\nIt has anti-inflammatory and antimicrobial properties and\nmay help manage inflammation associated with endometriosis.\nBerberine exhibits anti-inflammatory effects by modulating\nvarious inflammatory mediators, including cytokines and\nenzymes involved in the inflammatory response. It can inhibit\nthe activation of NF- \u0014B, a key transcription factor involved\nin inflammation. By reducing inflammation, berberine may\nhelp alleviate pain and reduce the inflammatory environment\nassociated with endometriosis. It showed hormonal regulatory\neffects in endometriosis. It has been reported to influence\nhormone levels, particularly estrogen. Berberine can modulate\nestrogen receptors and affect estrogen signaling pathways. By\nregulating estrogenic activity, berberine may help to control\nthe growth and development of endometriotic lesions. It\nexhibits anti-proliferative effects on various cells, including\nendometriotic cells. By suppressing the excessive proliferation\nof endometriotic cells, berberine may help to inhibit the growth\nand progression of endometriotic lesions ( Zhang et al., 2019).\nBerberine possess anti-angiogenic properties and help to\nlimit the blood supply to endometriotic lesions, hindering their\ngrowth and development. It exhibits antioxidant properties\nand can scavenge ROS and reduce oxidative stress. Oxidative\nstress is implicated in the pathogenesis of endometriosis. The\nantioxidant effects of berberine may help to counteract cellular\ndamage, reduce inflammation, and promote overall tissue health\nin endometriosis. It influences various signaling pathways\ninvolved in cell proliferation, survival, and invasion. It can\nmodulate pathways such as AMPK and mammalian target of\nrapamycin (mTOR), which are involved in cell growth and\nmetabolism. By interfering with these signaling pathways,\nberberine may help regulate cellular processes and inhibit the\ngrowth and invasiveness of endometriotic lesions ( Z. Gaurav et\nal., 2020; Gautam, 2022; Gu & Zhou, 2021; Warowicka et al.,\n2021; Zhou & Zhou , 2011).\nBerberine influence epigenetic modifications, such as histone\nacetylation and DNA methylation. Epigenetic alterations are\nimplicated to develop endometriosis. Berberine’s ability to\nmodify epigenetic patterns may help regulate gene expres-\nsion patterns, potentially influencing key genes involved in\nendometriosis pathogenesis. It has also been reported to have\nanti-fibrotic effects in various conditions. It can inhibit the\nactivation of fibroblasts and the deposition of extracellular\nmatrix components, helping to reduce fibrosis in endometriotic\nlesions. It has also been shown to regulate autophagy in\ndifferent contexts. It can induce autophagy or inhibit excessive\nautophagy, depending on the cellular context. By modulating\nN a t u r a l R e s o u r c e s f o r H u m a n H e a l t h 2024, 4, 75–88 | 78\n\nEkbbal et al View Article Online\nautophagy, berberine may influence cellular homeostasis and\nsurvival in endometriotic lesions ( Gu & Zhou , 2021; Saha &\nKhuda-Bukhsh, 2015).\nPaclitaxel is a chemotherapy medication that has been used\nin the treatment of various types of cancer, including ovarian\ncancer. While it is not a standard therapy for endometriosis\nor polycystic ovarian syndrome (PCOS), there is some research\nexploring its potential use in these conditions. Paclitaxel belongs\nto a class of medications known as taxanes. It works by\ninhibiting microtubule depolymerization, thereby disrupting\ncell division and preventing cancer cells from growing and\nmultiplying. Paclitaxel is administered intravenously. It is\nprimarily metabolized by the liver, and its metabolites are\neliminated through the bile and feces. It has a relatively long\nhalf-life, which can influence dosing schedules ( Chen et al. ,\n2022; Xu & Li, 2018).\nPaclitaxel acts on microtubules via binding and stabilizing\nthem and disrupts normal cellular processes, particularly in\nrapidly dividing cells such as endometriotic lesions. This\ndisruption leads to cell cycle arrest and prevents cell division and\nproliferation. Paclitaxel interferes with the normal progression\nof mitosis, the process of cell division. It specifically targets\nthe mitotic spindle apparatus, preventing its disassembly and\nresulting in mitotic arrest. This prevents the separation of\nchromosomes during cell division and leads to cell death. It\nalso triggers apoptosis, a process of programmed cell death,\nin endometriotic cells. It activates signaling pathways that\npromote apoptotic cell death, leading to the elimination of\nabnormal cells. This apoptotic effect is thought to contribute to\nthe reduction of endometriotic lesions (Li et al., 2022; Okimura\net al., 2018; Smith et al., 2022).\nPaclitaxel also exhibits anti-angiogenic properties and\ninhibits the proliferation of endothelial cells and disrupts\nthe formation of blood vessels, thereby reducing the blood\nsupply to endometriotic lesions and inhibiting their growth. It\nmodulates the immune response and affect the function and\nactivity of immune cells, such as T cells and dendritic cells.\nBy modulating the immune response, paclitaxel may help to\nregulate the immune environment surrounding endometriotic\nlesions, potentially reducing inflammation and promoting\nimmune-mediated clearance of abnormal cells ( R et al. , 2019;\nXu & Li , 2018; Yee et al., 2013). It also inhibit the migration\nand invasion of endometriotic cells. It disrupts the dynamics of\nthe cytoskeleton, preventing the rearrangement and extension\nof cellular structures necessary for cell movement thus it\nhelps to limit the spread and dissemination of endometriotic\nlesions (Ota et al., 2020).\nPaclitaxel modulate inflammatory responses by affecting the\nproduction and activity of pro-inflammatory cytokines and\nchemokines. In endometriosis, chronic inflammation is a\nkey factor contributing to the development and progression\nof the disease. Paclitaxel’s anti-inflammatory effects may\nhelp to reduce the inflammatory environment surrounding\nendometriotic lesions. It induces DNA damage in rapidly\ndividing cells, including endometriotic cells. It interferes\nwith DNA replication and promotes the formation of DNA\nadducts, which disrupt the integrity of the DNA molecule.\nThis leads to DNA damage and activates cellular mechanisms\ninvolved in DNA repair. Persistent DNA damage and impaired\nrepair processes can result in cell death ( Caillaud et al. , 2021;\nFerrandina et al., 2016). It can inhibit the activity of pathways\nsuch as the phosphoinositide 3-kinase (PI3K)/Akt pathway,\nwhich is associated with cell survival and proliferation. By\nmodulating these signaling pathways, paclitaxel can disrupt\nthe cellular processes necessary for the survival and growth of\nendometriotic lesions. It also has been reported to influence the\nexpression and activity of hormone receptors, such as estrogen\nreceptors, hence interfere with the hormonal environment\nnecessary for the growth and progression of endometriotic\nlesions (Caillaud et al. , 2021; Costa et al. , 2018; Ferrandina et\nal., 2016).\n2.2. Plants used for the treatment of endometriosis\nVitex agnus -castus, also known as chasteberry or vitex,\ncontain different chemical sonstituents sch as agnuside, cas-\nticin, vitexin, casticin acetate, rotundifuran, flavonoids (ori-\nentin, isoorientin, isovitexin, apigenin), essential oils (cineole,\nsabinene, limonene) agnuside glucoside, vitexilactone, 3-\nhydroxy-4,5-dimethoxybenzoic acid, casticin glucoside, 6’-O-\ntrans-p-coumaroylcasticin, 6’-O-trans-feruloylcasticin, vitexin-\n2′′-O-rhamnoside, 7-O-trans-p-coumaroylvitexin. It has been\ntraditionally used to regulate hormone levels in women. It may\nhelp balance estrogen and progesterone levels and alleviate some\nsymptoms of endometriosis ( Prilepskaya & Dovletkhanova ,\n2020).\nGinger is a root spice that contains several bioactive com-\npounds such as gingerols, shogaols, gingerdiols, zingerone, gin-\ngerenone a, paradols, sesquiterpenes, gingerdiones, zingiberene,\ncurcuminoids, etc. Essential oils, including gingerol. It has anti-\ninflammatory effects and may help alleviate pain and reduce\ninflammation in endometriosis ( Filho et al. , 2021). Green tea\ncontains catechins, which are natural antioxidants that have\nanti-inflammatory properties. Some studies have suggested that\ngreen tea extracts may help reduce the growth of endometrial\ntissue and alleviate symptoms ( Chen et al. , 2022; Man et al. ,\n2012). T raditional Chinese herbal medicine formulas have\nbeen used for centuries to manage gynecological conditions,\nincluding endometriosis. Herbal remedies such as Danazol\nand T ripterygium wilfordii Hook F (known as Lei Gong T eng)\nhave been studied for their potential benefits in reducing\npain and inflammation associated with endometriosis ( Xiao\net al. , 2002). Frankincense oil, derived from the resin of\nBoswellia trees, has been used in traditional medicine for its\nanti-inflammatory properties. It may help reduce inflammation\nand pain associated with endometriosis when used topically or\nin aromatherapy (Almeida-Da-Silva et al., 2022).\nChasteberry (Vitex agnus -castus) is an herb that may help\nbalance hormone levels by acting on the pituitary gland. It has\nbeen traditionally used to manage menstrual irregularities and\nhormone-related conditions such as endometriosis. Hormonal\nN a t u r a l R e s o u r c e s f o r H u m a n H e a l t h 2024, 4, 75–88 | 79\n\nEkbbal et al View Article Online\nFigure 1. Reported chemical constituents used in endometriosis.\nN a t u r a l R e s o u r c e s f o r H u m a n H e a l t h 2024, 4, 75–88 | 80\n\nEkbbal et al View Article Online\nregulation: Chasteberry is thought to exert its effects on\nendometriosis by modulating hormone levels, particularly\nprolactin and progesterone. It acts on the hypothalamus and\npituitary gland, leading to a decrease in prolactin secretion\nand an increase in progesterone production. By balancing\nhormone levels, chasteberry may help regulate the abnormal\nhormonal milieu associated with endometriosis, potentially\nreducing the growth and symptoms of endometriotic lesions.\nIt has also been found to influence dopamine activity in\nthe brain. It may enhance dopamine release or reduce\ndopamine degradation, resulting in an indirect effect on\nhormone regulation ( Mollazadeh et al. , 2020; Stute et al. ,\n2019; Van Die et al. , 2013). It can inhibit the production\nand activity of pro-inflammatory mediators, such as cytokines\nand prostaglandins. By reducing inflammation, it helps\nto alleviate pain and reduce the inflammatory environment\nassociated with endometriosis. It may have immunomodulatory\neffects, influencing immune cell function and the immune\nresponse ( Ogaly et al. , 2021). It can regulate the balance\nof immune cells and modulate the production of cytokines,\npotentially helping to reduce immune dysregulation and\ninflammation in endometriosis. It also exhibits antioxidant\nproperties, which can help counteract oxidative stress in\nendometriosis. It scavenges reactive oxygen species (ROS) and\nreduces oxidative damage, contributing to the overall reduction\nof cellular stress and inflammation ( Ibrahim et al., 2021).\nChasteberry regulate the menstrual cycle by influencing the\nbalance of hormones involved in menstrual cycle regulation,\nsuch as follicle-stimulating hormone (FSH) and luteinizing\nhormone (LH). By promoting a more regular and balanced\nmenstrual cycle, chasteberry may help to normalize the growth\nand shedding of endometrial tissue, potentially reducing the\ndevelopment and progression of endometriosis ( Azarnia et al. ,\n2007; Mayo, 1998). It is also reported to have anti-estrogenic\neffects, potentially inhibiting the effects of excessive estrogen\nin the body. It may compete with estrogen receptors or\nmodulate estrogen signaling pathways, leading to a reduction\nin estrogenic activity. As estrogen plays a crucial role in\nthe growth and proliferation of endometriotic lesions, the\nability of chasteberry to reduce estrogenic activity may help\nto control the progression of endometriosis. It has also been\nshown to affect prolactin levels in the body ( Mollazadeh et al. ,\n2020). Chasteberry is reported to possess analgesic properties,\npotentially helping to reduce pain and discomfort associated\nwith endometriosis ( Seidlova-Wuttke & Wuttke , 2019; Van\nDie et al. , 2013). Moreover, endometriosis has a significant\nimpact on psychological well-being, including mood swings,\nanxiety, and depression. Chasteberry has been suggested to\nhave positive effects on psychological symptoms by influencing\nneurotransmitter activity and promoting a sense of well-being,\nhence, by improving psychological well-being, chasteberry may\ncontribute to overall symptom relief and better quality of life in\nindividuals with endometriosis ( Van Die et al., 2013).\nAshwagandha, also known as Withania somnifera , is an\nadaptogenic herb used in traditional Ayurvedic medicine. It\nhas antioxidant and anti-inflammatory properties and may help\nregulate hormone levels and reduce stress, which could be\nbeneficial in managing endometriosis symptoms. Serrapeptase\nis an enzyme derived from the silkworm. It has anti-\ninflammatory properties and is believed to help break down and\ndissolve scar tissue and adhesions associated with endometriosis.\nHowever, more research is needed to determine its efficacy and\nsafety for this specific condition. Bee propolis is a resinous\nsubstance collected by bees from tree buds and used in their\nhives. It has anti-inflammatory, antioxidant, and antimicrobial\nproperties. Some studies have suggested that bee propolis may\nhelp reduce inflammation and alleviate symptoms associated\nwith endometriosis ( Azgomi et al. , 2018; Nishteswar, 2013;\nSankar, 2018).\nMagnolia bark extract obtained from Magnolia officinalis\nstem that exhibits anti-inflammatory and antioxidant properties\ndue to chemicals namely honokiol, magnolol, magnaldehyde,\nhonokiol glycoside, magnolol glycoside, dihydromagnolol,\ndihydrohonokiol, magnoflorine, norhonokiol, norisomagnolol,\netc. Some research suggests that magnolia bark extract\nmay help reduce pain and inflammation associated with\nendometriosis. ( Szałabska-Rąpała et al. , 2021). Magnolia\nofficinalis L. bark extract reduced the secretion of IL-6 and\nIL-8 from HGF-1 cells to 72.5 \u0006 28.6% and significantly\nreduces the secretion of matrix metalloproteinase 9 (MMP-9)\nand matrix metalloproteinase 2 (MMP-2) from U-937 cells to\n8.87 \u0006 7.97% compared to LPS-treated cells (100%). Magnolia\nofficinalis L. extract with same as 5 \u0016g/mL of Isodon japonicus\nL. extract exhibits potent anti-inflammatory effect.\nBlack cohosh ( Actaea racemosa ) is traditionally used to\nalleviate menopausal symptoms, but some studies suggest it may\nalso have anti-inflammatory properties and could potentially\nhelp manage endometriosis symptoms. Furthermore, it has\nbeen suggested that the effectiveness and safety of black cohosh\nproducts in alleviating symptoms associated with menopause\nexhibiting a significant role in reproductive associated disorders.\nthe majority of clinical trials represents that Actaea racemosa\nL. significantly makes better menopause and improve related\nsymptoms as well as the associated complications such as liver\ndisease, autoimmune diseases, or those taking medications that\nmay affect liver function against using products containing\nblack cohosh (Beer et al., 2013; Leach & Moore, 2012; Mahady\net al., 2006; Salari et al., 2021).\nVitex trifolia , also known as Indian beech or chaste tree,\nis an herb traditionally used in Ayurvedic medicine. It has\nbeen studied for its potential benefits in hormonal imbalances,\nincluding endometriosis ( Hakeem et al. , 2016; Parkhe &\nBharti, 2019; Wee et al. , 2020). Boswellia serrata , also\nknown as Indian frankincense, is an herbal extract that has\nbeen used in traditional medicine for its anti-inflammatory\nproperties. It may help reduce inflammation and alleviate pain\nassociated with endometriosis ( Azemi et al. , 2012). Myrrh is\na resin obtained from trees of the genus Commiphora used\nin traditional medicine for its anti-inflammatory and analgesic\nproperties. Myrrh essential oil or tincture may be used topically\nN a t u r a l R e s o u r c e s f o r H u m a n H e a l t h 2024, 4, 75–88 | 81\n\nEkbbal et al View Article Online\nT able 1\nMedicinal plants and their reported pharmacological action against endometriosis.\nS. No. Plant/source Chemical constituents Mechanism of action\n1. Vitex agnus-castus (chasteberry or vitex) Agnuside, casticin, vitexin, casticin acetate,\nrotundifuran, flavonoids (orientin, isoorientin,\nisovitexin, apigenin), essential oils (cineole,\nsabinene, limonene) agnuside glucoside,\nvitexilactone, 3-hydroxy-4,5-dimethoxybenzoic\nacid, casticin glucoside,\n6’-O-trans-p-coumaroylcasticin,\n6’-O-trans-feruloylcasticin,\nvitexin-2′′-O-rhamnoside,\n7-O-trans-p-coumaroylvitexin\nRegulates estrogen and progesterone\nlevels and alleviate some symptoms of\nendometriosis\n2. Zingiber officinale (Ginger) Gingerols, shogaols, gingerdiols, zingerone,\ngingerenone a, paradols, sesquiterpenes,\ngingerdiones, zingiberene, curcuminoids, etc\nExhibits anti-inflammatory effects and\nmay help alleviate pain and reduce\ninflammation in endometriosis\n3. Camellia sinensis (Green tea) Catechins, phenol and flavonoids Reduce the growth of endometrial\ntissue\n4. Withania somnifera (Ashwagandha) Polyphenols, steroids such as Withanolide A, B Exhibits antioxidant and\nanti-inflammatory properties and may\nhelp regulate hormone levels and\nreduce stress\n5. Magnolia officinalis (Magnolia) Honokiol, magnolol, magnaldehyde, honokiol\nglycoside, magnolol glycoside, dihydromagnolol,\ndihydrohonokiol, magnoflorine, norhonokiol,\nnorisomagnolol, etc\nHelp to reduce pain and inflammation\nassociated with endometriosis\n6. Actaea racemose (Black cohosh) Biphenyl compounds, caffeic acids, flavonoids,\nfree radical scavengers, lignans, phenols,\nphenylacetates, picrates,\nAlleviate menopausal symptoms,\nexhibits anti-inflammatory activity\nand potentially help to manage\nendometriosis symptoms.\n7. Vitex trifolia (Indian beech or chaste tree) Matairesinol 4′-O-\f-D- glucopyranoside,\necdysone, 20-hydroxyecdysone\n2,3-monoacetonide, turkesterone,\n20-hydroxyecdysone, and polypodine\nPotential benefits in hormonal\nimbalances, including endometriosis\n8. Boswellia serrata (Indian frankincense) Monoterpenes, diterpenes, triterpenes, tetracyclic\ntriterpenic acids, pentacyclic triterpenic acids\nacetyl-\f-boswellic acid, \f-boswellic acid,\n11-keto-\f-boswellic acid and\nacetyl-11-keto-\f-boswellic acid.\nExhibits anti-inflammatory properties.\nIt may help reduce inflammation and\nalleviate pain associated with\nendometriosis.\nto help manage endometriosis symptoms ( Rahmani et al. ,\n2022; Suliman et al. , 2022). Flaxseed is rich in omega-\n3 fatty acids and lignans, which possess anti-inflammatory\nproperties. It may help regulate hormone levels and reduce\ninflammation associated with endometriosis. Ground flaxseed\ncan be added to meals or smoothies ( Collins et al. , 2003).\nDandelion root has been used in traditional medicine for its\ndiuretic and anti-inflammatory properties. It may help support\nliver function, reduce inflammation, and manage symptoms\nof endometriosis ( Bont et al. , 2019; Mitkowski & Abawi ,\n2002). Licorice root has anti-inflammatory and antispasmodic\nproperties. It may help reduce inflammation and alleviate pain\nassociated with endometriosis. However, licorice root should be\nused with caution due to its potential effects on blood pressure\nand hormone levels (Minnetti et al., 2022). Red clover contains\nisoflavones, which are phytoestrogens that may help regulate\nestrogen levels. It has been studied for its potential benefits\nin managing hormonal imbalances and reducing inflammation\nassociated with endometriosis ( Hloucalová et al. , 2016; Jing et\nal., 2021; Riggi et al., 2021). The potential medicinal plants that\nhas been used for endometriosis are summarized in T able1.\n2.3. TherapeuƟc targets of recent pharmaceuƟcals in\nendometriosis\nThere are several pharmaceutical formulations used in the\nmanagement of endometriosis. The specific treatment approach\nmay vary depending on factors such as the severity of symptoms,\nthe desire for fertility, and individual patient characteris-\ntics. Nonsteroidal anti-inflammatory drugs (NSAIDs) such\nas ibuprofen, naproxen, and diclofenac are often prescribed\nto help relieve pain and reduce inflammation associated\nwith endometriosis. They work by inhibiting prostaglandin\nproduction, which can alleviate pain symptoms. Various\nhormonal contraceptives such as estrogen and progestin,\ncontraceptive patches, progestin-only pills, and contraceptive\ninjections, are commonly used to manage endometriosis. These\nmedications help regulate hormone levels and reduce the growth\nof endometrial tissue ( Brown et al. , 2017; Efstathiou et al. ,\n2005; Stewart & Deb, 2016).\nGonadotropin-releasing hormone (GnRH) agonists and\nantagonists work by suppressing the production of estrogen,\nwhich can lead to the shrinkage of endometriotic implants\nN a t u r a l R e s o u r c e s f o r H u m a n H e a l t h 2024, 4, 75–88 | 82\n\nEkbbal et al View Article Online\nand a reduction in symptoms. Medications such as leuprolide,\ngoserelin, and nafarelin fall into this category. GnRH agonists\nand antagonists have been extensively studied and utilized\nin the treatment of endometriosis. These medications target\nthe GnRH receptor in the pituitary gland, leading to the\nsuppression of gonadotropin release and subsequent reduction\nin ovarian estrogen production. This hormonal manipulation\nresults in a hypoestrogenic state, which can alleviate symptoms\nassociated with endometriosis and promote regression of\nendometrial lesions. GnRH agonists, such as leuprolide\nand goserelin, initially cause an initial surge in gonadotropin\nrelease before desensitizing the pituitary gland and ultimately\ndownregulating GnRH receptors. This downregulation leads to\nthe suppression of ovarian estrogen production, inducing a state\nof reversible pseudomenopause. While effective in alleviating\npain and reducing endometriotic lesions, GnRH agonists are\nassociated with side effects such as hot flashes, vaginal dryness,\nand bone loss ( Hu et al. , 2022; Kumar & Sharma , 2014;\nLeyland et al. , 2021). T o mitigate these adverse effects,\nadd-back hormonal therapy, including low-dose estrogen and\nprogestin supplementation, is often prescribed concurrently.\nGnRH antagonists, such as cetrorelix and ganirelix, work by\ndirectly blocking the GnRH receptor without an initial surge\nin gonadotropin release. This leads to rapid and reversible\nsuppression of gonadotropin release and estrogen production.\nGnRH antagonists offer a more convenient dosing regimen\nand may have a lower risk of flare-up symptoms compared to\nGnRH agonists. However, their long-term efficacy and safety\nin endometriosis treatment require further investigation. While\nGnRH agonists and antagonists have demonstrated efficacy in\nmanaging endometriosis-related pain and lesions, their use is\ntypically limited to short-term treatment due to the potential\nfor adverse effects and the need for add-back therapy to mitigate\nhypoestrogenic symptoms. The decision to utilize GnRH\nagonists or antagonists should be based on individual patient\ncharacteristics, treatment goals, and consideration of potential\nside effects. Ongoing research is focused on optimizing\nthe duration and combination therapies to maximize the\nbenefits and minimize the drawbacks of these pharmacological\ninterventions in endometriosis management ( Hu et al. , 2022;\nKumar & Sharma, 2014).\nProgestins are synthetic forms of progesterone, prescribed\nin various formulations, including oral pills, injections, or\nintrauterine devices (IUDs). Progestins help regulate hormone\nlevels and can reduce the growth of endometrial tissue.\nProgestins exert their effect by inhibiting the secretion of FSH\nand LH from the pituitary gland. This leads to the suppression\nof ovulation, thereby reducing cyclic hormonal fluctuations and\nthe subsequent growth and proliferation of endometrial tissue\noutside the uterus ( Gezer & Oral, 2015).\nProgestins promote the differentiation of endometrial cells\ninto a decidualized state, similar to the changes that occur in\nthe endometrium during pregnancy. Decidualization leads to\nreduced cell proliferation and angiogenesis, potentially causing\nregression and inhibition of endometriotic lesions. It also\npossess anti-inflammatory properties, which can help reduce\nthe inflammatory response associated with endometriosis. They\ninhibit the production of pro-inflammatory cytokines and\nchemokines, thereby attenuating the recruitment and activation\nof immune cells in the endometriotic lesions. Progestins can\nmodulate the activity of estrogen receptors in the endometrium.\nBy competing with estrogen for binding to the receptors,\nprogestins counteract the proliferative effects of estrogen on\nendometrial and endometriotic tissues. This antagonistic\neffect on estrogen signaling helps to control the growth and\ndevelopment of endometriotic lesions ( Angioni et al. , 2014;\nV ercellini et al., 2016).\nDanazol is a synthetic androgen derivative that has been\nused in the treatment of endometriosis for several decades. Its\nmechanism of action involves a combination of hormonal and\nnon-hormonal effects, which contribute to its therapeutic effi-\ncacy in managing endometriosis. Suppression of gonadotropin\nsecretion: Danazol acts on the hypothalamic-pituitary-ovarian\naxis to suppress the release of FSH and LH. This leads to a state\nof reversible ovarian suppression, resulting in a hypoestrogenic\nenvironment. The reduced estrogen levels help to inhibit the\ngrowth and development of endometriotic lesions ( Selak et al. ,\n2007).\nDanazol has anti-estrogenic properties, which means it\ncompetes with estrogen for binding to estrogen receptors.\nBy occupying these receptors, danazol blocks the proliferative\neffects of estrogen on the endometrial and endometriotic tissues.\nThis results in the suppression of cell proliferation and reduces\nthe size and activity of endometriotic lesions. Aromatase\ninhibitors, such as letrozole and anastrozole, work by inhibiting\nthe enzyme aromatase, which is responsible for the production\nof estrogen. By reducing estrogen levels, aromatase inhibitors\ncan help suppress the growth of endometrial tissue. Danazol\ndirectly acts on the pituitary gland to suppress the release\nof FSH and LH. This effect reduces ovarian function and\nsuppresses estrogen production, contributing to the inhibition\nof endometriosis growth. Inhibition of steroidogenesis:\nDanazol inhibits the enzymatic activity of various steroidogenic\nenzymes, including 17-alpha hydroxylase and 17,20-lyase. This\nleads to a decrease in the synthesis of ovarian androgens and\nestrogen precursors, further contributing to the hypoestrogenic\nstate. Modulation of the immune system: Danazol has\nimmunomodulatory effects, including suppression of immune\ncell function, alteration of cytokine production, and reduction\nof inflammatory response. These actions help to mitigate the\ninflammatory environment associated with endometriosis and\nalleviate symptoms ( Igarashi, 1990; Selak et al. , 2007; Wright\net al., 1995).\nFurthermore, selective progesterone receptor modulators\n(SPRMs), such as ulipristal acetate, act on progesterone\nreceptors and can have both progestin and anti-progestin effects.\nThey are used to manage moderate to severe endometriosis-\nassociated pain and can help reduce the size of endometriotic\nlesions. SPRMs act as antagonists on progesterone receptors\nin endometrial and endometriotic tissues, inhibiting the\nN a t u r a l R e s o u r c e s f o r H u m a n H e a l t h 2024, 4, 75–88 | 83\n\nEkbbal et al View Article Online\nproliferative effects of estrogen. By blocking the activity of\nestrogen in these tissues, SPRMs help to reduce the growth\nand development of endometriotic lesions. SPRMs induce\na state of progesterone resistance in the endometrium and\nendometriotic lesions. This resistance prevents the normal\nprogesterone-mediated decidualization process, which is essen-\ntial for the establishment and maintenance of endometriotic\nlesions. By disrupting this process, SPRMs contribute to\nthe regression and inhibition of endometriosis. SPRMs have\nanti-inflammatory properties, which can help to mitigate the\ninflammatory response associated with endometriosis. They\nsuppress the production of various cytokines and chemokines,\nthereby reducing immune cell recruitment and activation in\nendometriotic lesions (Chwalisz et al., 2005; Singh et al., 2020;\nWhitaker et al., 2014).\n3. CONCLUSION\nIn conclusion, the phytopharmacology and chemistry of\nmedicinal plants used traditionally for endometriosis and offer\npromising avenues for the development of alternative therapies.\nThe identified medicinal plants possess diverse pharmacological\nproperties and bioactive constituents that target multiple\npathways involved in endometriosis pathogenesis. The anti-\ninflammatory, analgesic, antioxidant, immunomodulatory, and\nhormone-regulating effects of these plants provide potential\nbenefits in managing endometriosis-related symptoms and\nimproving reproductive outcomes. However, further research\nis needed to elucidate the precise mechanisms of action,\noptimize dosage regimens, and evaluate the safety and efficacy\nof these natural remedies. Integrating traditional knowledge\nwith modern scientific approaches will contribute to the\ndevelopment of novel therapeutic agents for the effective\nmanagement of endometriosis.\n4. ACKNOWLEDGEMENT\nThe authors would like to acknowledge IIMT College of\nMedical Sciences, IIMT University, Meerut Uttar Pradesh-\n250001 for providing the facilities to conduct the study.\nCONFLICTS OF INTEREST\nThe authors declare no conflict of interest.\nORCID\nRustam Ekbbal 0000-0003-1862-9280\nAakash Kumar Jaiswal 0000-0001-8459-2610\nMansi Aggarwal 0000-0001-5396-5365\nMhaveer Singh 0000-0001-9951-5685\nShadab Ali 0009-0007-6832-0907\nSayad Ahad Ali 0000-0002-6837-1268\nGaurav Gautam 0000-0002-0530-0788\nAUTHOR CONTRIBUTIONS\nGG - Research concept and design, RE, AKJ, MA,MS, SAA\n- Collection and/or assembly of data, MA - Data analysis and\ninterpretation, RA, SAA, GG - Writing the article, MS, GG -\nCritical revision of the article, GG - Final approval of the article.\nREFERENCES\nAbramiuk, M., Grywalska, E., Małkowska, P ., Sierawska, O.,\nHrynkiewicz, R., Niedźwiedzka-Rystwej, P ., 2022. The Role\nof the Immune System in the Development of Endometriosis. Cells.\n11, 2028. https://doi.org/10.3390/cells11132028\nAgarwal, S.K., Chapron, C., Giudice, L.C., Laufer, M.R., Leyland, N.,\nMissmer, S.A., Singh, S.S., T aylor, H.S., 2019. Clinical diagnosis of\nendometriosis: a call to action. American Journal of Obstetrics and\nGynecology. 354, e1-354.e12. https://doi.org/10.1016/j.ajog.2018\n.12.039\nAgostinis, C., Zorzet, S., De Leo, R., Zauli, G., De Seta, F ., Bulla, R.,\n2015. The combination of N-acetyl cysteine, alpha-lipoic acid, and\nbromelain shows high anti-inflammatory properties in novel in vivo\nand in vitro models of endometriosis. Mediators of Inflammation.\n2015, 918089. https://doi.org/10.1155/2015/918089\nAhmad, S., Zahiruddin, S., Parveen, B., Basist, P ., Parveen, A., Gaurav,\nParveen, R., Ahmad, M., 2021. Indian Medicinal Plants and\nFormulations and Their Potential Against COVID-19-Preclinical and\nClinical Research. Frontiers in Pharmacology. 11, 578970. https://\ndoi.org/10.3389/fphar.2020.578970\nAkyol, A., Şimşek, M., İlhan, R., Can, B., Baspinar, M., Akyol, H.,\nGül, H.F ., Gürsu, F ., Kavak, B., Akın, M., 2016. Efficacies of\nvitamin D and omega-3 polyunsaturated fatty acids on experimental\nendometriosis. T aiwanese Journal of Obstetrics and Gynecology. 55,\n835–839. https://doi.org/10.1016/j.tjog.2015.06.018\nAlmeida-Da-Silva, C.L.C., Sivakumar, N., Asadi, H., Chang-Chien, A.,\nQoronfleh, M.W ., Ojcius, D.M., Essa, M.M., 2022. Effects of Frank-\nincense Compounds on Infection, Inflammation, and Oral Health.\nMolecules. 13, 4174. https://doi.org/10.3390/molecules27134174\nAngioni, S., Cofelice, V ., Pontis, A., Tinelli, R., Socolov, R., 2014.\nNew trends of progestins treatment of endometriosis. Gynecological\nEndocrinology. 30, 769–773. https://doi.org/10.3109/09513590\n.2014.950646\nArablou, T ., Kolahdouz-Mohammadi, R., 2018. Curcumin and\nendometriosis: Review on potential roles and molecular mechanisms.\nBiomedicine & Pharmacotherapy. 97, 91–97. https://doi.org/10\n.1016/j.biopha.2017.10.119\nAzarnia, M., Ejtemaee-Mehr, S., Shakoor, A., Ansari, A., 2007. Effects of\nVitex agnus castus on mice fetus development. Acta Medica Iranica.\n45, 263–270.\nAzemi, M.E., Namjoyan, F ., Khodayar, M.J., Ahmadpour, F ., Padok, A.D.,\nPanahi, M., 2012. The antioxidant capacity and anti-diabetic effect of\nBoswellia serrata triana and planch aqueous extract in fertile female\ndiabetic rats and the possible effects on reproduction and histological\nchanges in the liver and kidneys. Jundishapur Journal of Natural\nPharmaceutical Products. 7, 168–175.\nAzgomi, R.N.D., Zomorrodi, A., Nazemyieh, H., Fazljou, S.M.B.,\nBazargani, H.S., Nejatbakhsh, F ., Jazani, A.M., Asrbadr, Y.A., 2018.\nEffects of Withania somnifera on Reproductive System: A Systematic\nReview of the Available Evidence. BioMed Research International.\n2018, 4076430. https://doi.org/10.1155/2018/4076430\nBahat, P .Y., Ayhan, I., Ozdemir, E.U., Inceboz, Ü., Oral, E., 2022.\nDietary supplements for treatment of endometriosis: A review.\nActa Biomedica. 93, e2022159. https://doi.org/10.23750/abm.v93i1\n.11237\nBarnard, N.D., Holtz, D.N., Schmidt, N., Kolipaka, S., Hata, E., Sut-\nN a t u r a l R e s o u r c e s f o r H u m a n H e a l t h 2024, 4, 75–88 | 84\n\nEkbbal et al View Article Online\nton, M., Znayenko-Miller, T ., Hazen, N.D., Cobb, C., Kahleova, H.,\n2023. Nutrition in the prevention and treatment of endometriosis: A\nreview. Frontiers in Nutrition. 17, 1089891.https://doi.org/10.3389/\nfnut.2023.1089891\nBasist, P ., Parveen, B., Zahiruddin, S., Gautam, G., Parveen, R.,\nKhan, M.A., Krishnan, A., Shahid, M., Ahmad, S., 2022. Potential\nnephroprotective phytochemicals: Mechanism and future prospects.\nJournal of Ethnopharmacology. 283, 114743. https://doi.org/10\n.1016/j.jep.2021.114743\nBeer, A.M., Osmers, R., Schnitker, J., Bai, W ., Mueck, A.O., Meden, H.,\n2013. Efficacy of black cohosh ( Cimicifuga racemosa ) medicines\nfor treatment of menopausal symptoms-comments on major state-\nments of the Cochrane Collaboration report 2012 “black cohosh\n(Cimicifuga spp.) for menopausal symptoms (review). Gynecological\nEndocrinology. 29, 1022–1025. https://doi.org/10.3109/09513590\n.2013.831836\nBont, Z., Pfander, M., Robert, C., Huber, M., Poelman, E., Raaijmak-\ners, C., Erb, M., 2019. Adapted dandelions increase seed dispersal\npotential when they are attacked by root herbivores. Proceedings of the\nRoyal Society B: Biological Sciences. 287, 20192930. https://doi.org/\n10.1098/rspb.2019.2930\nBrown, J., Crawford, T .J., Allen, C., Hopewell, S., Prentice, A.,\n2017. Nonsteroidal anti-inflammatory drugs for pain in women\nwith endometriosis. Cochrane Database of Systematic Reviews. 1,\nCD004753. https://doi.org/10.1002/14651858.cd004753.pub4\nCaillaud, M., Patel, N.H., T oma, W ., White, A., Thompson, D., Mann, J.,\nT ran, T .H., Roberts, J.L., Poklis, J.L., Bigbee, J.W ., Fang, X.,\nGewirtz, D.A., Damaj, M.I., 2021. A fenofibrate diet prevents\npaclitaxel-induced peripheral neuropathy in mice. Cancers. 13, 69.\nhttps://doi.org/10.3390/cancers13010069\nCampos, K.K.D., Araújo, G.R., Martins, T .L., Bandeira, A.C.B.,\nCosta, G., De, P ., T alvani, A., Garcia, C.C.M., Oliveira, L.A.M.,\nCosta, D.C., Bezerra, F .S., 2017. The antioxidant and anti-\ninflammatory properties of lycopene in mice lungs exposed to cigarette\nsmoke. The Journal of Nutritional Biochemistry. 48, 9–20. https://\ndoi.org/10.1016/j.jnutbio.2017.06.004\nCao, Y., Zhuang, M.F ., Yang, Y., Xie, S.W ., Cui, J.G., Cao, L.,\nZhang, T .T ., Zhu, Y., 2014. Preliminary Study of Quercetin Affecting\nthe Hypothalamic-Pituitary-Gonadal Axis on Rat Endometriosis\nModel. Evidence-Based Complementary and Alternative Medicine.\n2014, 781684. https://doi.org/10.1155/2014/781684\nChanjitwiriya, K., Roytrakul, S., Kunthalert, D., 2020. Quercetin nega-\ntively regulates IL-1\f production in Pseudomonas aeruginosa-infected\nhuman macrophages through the inhibition of MAPK/NLRP3\ninflammasome pathways. PLoS One. 15, e0237752. https://doi.org/\n10.1371/journal.pone.0237752\nChen, M., Zhang, Y., Xu, M., Liu, D., Yang, Y., Yao, S., 2022.\nPrimary high-grade serous cancer arising from uterosacral ligament\nendometriosis: two case reports. Journal of International Med-\nical Research. 50, 03000605221109373. https://doi.org/10.1177/\n03000605221109373\nChowdhury, I., Banerjee, S., Driss, A., Xu, W ., Mehrabi, S., Nezhat, C.,\nSidell, N., T aylor, R.N., Thompson, W .E., 2019. Curcumin\nattenuates proangiogenic and proinflammatory factors in human\neutopic endometrial stromal cells through the NF- \u0014B signaling\npathway. Journal of Cellular Physiology. 234, 6298–6312. https://\ndoi.org/10.1002/jcp.27360\nChwalisz, K., Perez, M.C., Demanno, D., Winkel, C., Schubert, G.,\nElger, W ., 2005. Selective progesterone receptor modulator develop-\nment and use in the treatment of leiomyomata and endometriosis.\nEndocrine Reviews. 26, 423–438. https://doi.org/10.1210/er.2005\n-0001\nClower, L., Fleshman, T ., Geldenhuys, W .J., Santanam, N., 2022.\nT argeting Oxidative Stress Involved in Endometriosis and Its Pain.\nBiomolecules. 12, 1085. https://doi.org/10.3390/biom12081055\nCollins, T .F .X., Sprando, R.L., Black, T .N., Olejnik, N., Wiesenfeld, P .W .,\nBabu, U.S., Bryant, M., Flynn, T .J., Ruggles, D.I., 2003. Effects of\nflaxseed and defatted flaxseed meal on reproduction and development\nin rats. Food and Chemical T oxicology. 41, 819–834.https://doi.org/\n10.1016/S0278-6915(03)00033-4\nCosta, R.L.B., Han, H.S., Gradishar, W .J., 2018. T argeting the\nPI3K/AKT/mTOR pathway in triple-negative breast cancer: a review.\nBreast Cancer Research and T reatment. 169, 397–406. https://doi\n.org/10.1007/s10549-018-4697-y\nEfstathiou, J.A., Sampson, D.A., Levine, Z., Rohan, R.M.,\nZurakowski, D., Folkman, J., Amato, R.J., Rupnick, M.A.,\n2005. Nonsteroidal antiinflammatory drugs differentially suppress\nendometriosis in a murine model. Fertility and Sterility. 83, 171–181.\nhttps://doi.org/10.1016/j.fertnstert.2004.06.058\nFerrandina, G., Palluzzi, E., Fanfani, F ., Gentileschi, S., Valentini, A.L.,\nMattoli, M.V ., Pennacchia, I., Scambia, G., Zannoni, G., 2016.\nEndometriosis-associated clear cell carcinoma arising in caesarean\nsection scar: A case report and review of the literature. World Journal\nof Surgical Oncology. 14, 300. https://doi.org/10.1186/s12957-016\n-1054-7\nFilho, J.M.D.M., Neto, J.N., Gomes, L.M.R.D.S., Ramos, I.S.F .,\nOliveira, S.S.R., Melo, G.C.F ., Silva, L.A., Moura, E.C.R.,\nLeal, P .D.C., 2021. Zingiber officinale Roscoe (Ginger) as a Com-\nplementary Option for Clinical T reatment of Endometriosis: An\nExperimental Study in Rats. Journal of Medicinal Food. 24, 342–347.\nhttps://doi.org/10.1089/jmf.2019.0320\nGaurav, Khan, M.U., Basist, P ., Zahiruddin, S., Ibrahim, M., Parveen, R.,\nKrishnan, A., Ahmad, S., 2022. Nephroprotective potential of\nBoerhaavia diffusa and Tinospora cordifolia herbal combination against\ndiclofenac induced nephrotoxicity. South African Journal of Botany.\n151, 238–247. https://doi.org/10.1016/j.sajb.2022.01.038\nGaurav, Sharma, I., Khan, M.U., Zahiruddin, S., Basist, P ., Ahmad, S.,\n2023. Multi-Mechanistic and Therapeutic Exploration of Nephropro-\ntective Effect of T raditional Ayurvedic Polyherbal Formulation Using\nIn Silico, In Vitro and In Vivo Approaches. Biomedicines. 11, 168.\nhttps://doi.org/10.3390/biomedicines11010168\nGaurav, Z., Parveen, S., Ibrahim, B., Sharma, M., Sharma, I., Sharma, S.,\nParveen, A.K., Ahmad, R., S., 2020. TLC-MS Bioautography-\nBased Identification of Free-Radical Scavenging, \u000b-Amylase, and \u000b-\nGlucosidase Inhibitor Compounds of Antidiabetic T ablet BGR-34.\nACS Omega. 5, 29688–29697. https://doi.org/10.1021/acsomega\n.0c02995\nGautam, G., 2022. Network Pharmacology-Based Validation of T ra-\nditional Therapeutic Claim of Momordica charantiain Alleviating\nDiabetic Nephropathy. Journal of CAM Research Progress. 1, 102.\nhttps://doi.org/10.33790/jcrp1100102\nGautam, G., Parveen, B., Khan, M.U., Sharma, I., Sharma, A.K.,\nParveen, R., Ahmad, S., 2021. A systematic review on nephron\nprotective AYUSH drugs as constituents of NEERI-KFT (A tradi-\ntional Indian polyherbal formulation) for the management of chronic\nkidney disease. Saudi Journal of Biological Sciences. 28, 6441–6453.\nhttps://doi.org/10.1016/j.sjbs.2021.07.008\nGautam, G., Parveen, R., Ahmad, S., 2023. LC-MS-based Metabolomics\nof Medicinal Plants, and others, (Eds.), Omics Studies of Medicinal\nPlants. CRC Press, p. 24. http://doi.org/10.1201/9781003179139-9\nGezer, A., Oral, E., 2015. Progestin therapy in endometriosis. Womens\nHealth, 643–652. https://doi.org/10.2217/whe.15.42\nGu, Y., Zhou, Z., 2021. Berberine inhibits the proliferation, invasion\nand migration of endometrial stromal cells by downregulating miR-\nN a t u r a l R e s o u r c e s f o r H u m a n H e a l t h 2024, 4, 75–88 | 85\n\nEkbbal et al View Article Online\n429. Molecular Medicine Reports. 23, 416. https://doi.org/10.3892/\nmmr.2021.12055\nHakeem, A., Yusof, N.R.S.M., Jahidin, N., Hasan, A.H., Mohsin, M.H.,\nWahab, H.F ., I., 2016.Vitex Species: Review on Phytochemistry and\nPouch Design for Nutritional Benefits. Scientific Research Journal.\nHarris, H.R., Chavarro, J.E., Malspeis, S., Willett, W .C., Missmer, S.A.,\n2013. Dairy-food, calcium, magnesium, and vitamin D intake and\nendometriosis: A prospective cohort study. American Journal of\nEpidemiology. 177, 420–430. https://doi.org/10.1093/aje/kws247\nHloucalová, P ., Skládanka, J., Horký, P ., Klejdus, B., Pelikán, J., Kno-\ntová, D., 2016. Animals. 6, 43. https://doi.org/10.3390/ani6070043\nHu, K.L., Chen, Z., Li, X., Cai, E., Yang, H., Chen, Y., Wang, C.,\nJu, L., Deng, W ., Mu, L., 2022. Advances in clinical applications\nof kisspeptin-GnRH pathway in female reproduction. Reproductive\nBiology and Endocrinology. 20, 81. https://doi.org/10.1186/s12958\n-022-00953-y\nIbrahim, F .M., Ibrahim, A.Y., El-Newary, S.A., Hendawy, S.F ., Maho-\nmoodally, M.F ., 2021. Vitex agnus-castus L. (Chasteberry) extracts\nshows in vitro and in vivo anti-inflammatory and anti-tumor\npropensities via reduction of cyclooxygenase-2 activity and oxidative\nstress complications. South African Journal of Botany. 143, 363–373.\nhttps://doi.org/10.1016/j.sajb.2021.02.001\nIgarashi, M., 1990. A New Therapy for Pelvic Endometriosis and Uterine\nAdenomyosis: Local Effect of Vaginal and Intrauterine Danazol\nApplication. Asia-Oceania Journal of Obstetrics and Gynaecology. 16,\n1–12. https://doi.org/10.1111/j.1447-0756.1990.tb00207.x\nJafarinia, M., Hosseini, M.S., Kasiri, N., Fazel, N., Fathi, F .,\nHakemi, M.G., Eskandari, N., 2020. Quercetin with the potential\neffect on allergic diseases. Allergy, Asthma & Clinical Immunology.\n16, 36. https://doi.org/10.1186/s13223-020-00434-0\nJing, S., Kryger, P ., Markussen, B., Boelt, B., 2021. Pollination and Plant\nReproductive Success of T wo Ploidy Levels in Red Clover ( T rifolium\npratense L.). Frontiers in Plant Science. 12, 720069. https://doi.org/\n10.3389/fpls.2021.720069\nKhan, A., Zahiruddin, S., Ibrahim, M., Basist, P ., Gaurav, Parveen, R.,\nUmar, S., Ahmad, S., 2021. Thin layer chromatography-mass\nspectrometry bioautographic identification of free radical scavenging\ncompounds and metabolomic profile of Carica papaya linn. fruit\nand seeds using high-performance thin-layer chromatography, gas\nchromatography-mass spectro. Pharmacognosy Magazine. 17, s21–\ns28. http://www.phcog.com/text.asp?2021/17/5/21/318023\nKhan, M.U., Gaurav, Zahiruddin, S., Basist, P ., Krishnan, A., Parveen, R.,\nAhmad, S., 2022. Nephroprotective potential of Sharbat-e-Bazoori\nMotadil (sugar-free) in HEK-293 cells and Wistar rats against cisplatin\ninduced nephrotoxicity. J. King Saud Univ. - Sci. 34, 101839.https://\ndoi.org/10.1016/j.jksus.2022.101839\nKhan, M.U., Gautam, G., Jan, B., Zahiruddin, S., Parveen, R., Ahmad, S.,\n2022. Vitamin D from V egetable VV Sources: Hope for the Future.\nPhytomedicine Plus. 2, 100248. https://doi.org/10.1016/j.phyplu\n.2022.100248\nKhanaki, K., Nouri, M., Ardekani, A.M., Ghassemzadeh, A., Shahnazi, V .,\nSadeghi, M.R., Darabi, M., Mehdizadeh, A., Dolatkhah, H.,\nSaremi, A., Imani, A.R., Rahimipour, A., 2012. Evaluation of\nthe relationship between endometriosis and omega-3 and omega-6\npolyunsaturated fatty acids. Iranian Biomedical Journal. 16, 38–43.\nhttps://doi.org/10.6091/ibj.1025.2012\nKim, S.Y., Kyaw, Y.Y., Seong, M.S., Kim, K.H., Cheong, J., 2019.\nCurcumin suppresses an endometrial cell inflammation through\ninhibition of SREBP-1. Integrative Molecular Medicine. 6, 1–6.\nhttps://doi.org/10.15761/IMM.1000384\nKim, T .H., Jo, S., Park, Y., Lee, H.H., Chung, S.H., Lee, W .S., 2013.\nDifferences in omega-3 and fatty acid profiles between patients with\nendometriosis and those with a functional ovarian cyst. Journal of\nObstetrics and Gynaecology. 33, 597–600. https://doi.org/10.3109/\n01443615.2013.786029\nKoninckx, P .R., Fernandes, R., Ussia, A., Schindler, L., Wattiez, A., Al-\nSuwaidi, S., Amro, B., Al-Maamari, B., Hakim, Z., T ahlak, M.,\n2021. Pathogenesis Based Diagnosis and T reatment of Endometriosis.\nFrontiers in Endocrinology. 12, 745548.https://doi.org/10.1136/bmj\n-2022-070750\nKumar, P ., Sharma, A., 2014. Gonadotropin-releasing hormone analogs:\nUnderstanding advantages and limitations. Journal of Human\nReproductive Sciences. 7, 170–174. https://doi.org/10.4103/0974\n-1208.142476\nKuttan, R., Bhanumathy, P ., Nirmala, K., George, M.C., 1985. Potential\nanticancer activity of turmeric ( Curcuma longa). Cancer Letters. 29,\n197–202. https://doi.org/10.1016/0304-3835(85)90159-4\nLeach, M.J., Moore, V ., 2012. Black cohosh ( Cimicifuga spp.) for\nmenopausal symptoms. Cochrane Database of Systematic Reviews.\n2012, CD007244. https://doi.org/10.1002/14651858.CD007244\n.pub2\nLete, I., Mendoza, N., Viuda, E.D.L., Carmona, F ., 2018. Effectiveness\nof an antioxidant preparation with N-acetyl cysteine, alpha lipoic acid\nand bromelain in the treatment of endometriosis-associated pelvic\npain: LEAP study. European Journal of Obstetrics & Gynecology\nand Reproductive Biology. 228, 221–224. https://doi.org/10.1016/\nj.ejogrb.2018.07.002\nLeyland, N., Estes, S.J., Lessey, B.A., Advincula, A.P ., T aylor, H.S., 2021.\nA Clinician’s Guide to the T reatment of Endometriosis with Elagolix.\nJournal of Women’s Health. 30, 569–578. https://doi.org/10.1089/\njwh.2019.8096\nLi, B., Wang, Y., Wang, Yue, Li, S., Liu, K., 2022. https://doi.org/\n10.3389/fonc.2022.832228\nLin, Z., Fan, W ., Yu, X., Liu, J., Liu, P ., 2022. Research into the\nmechanism of intervention of SanQi in endometriosis based on\nnetwork pharmacology and molecular docking technology. Medicine.\n101, e30021. https://doi.org/10.1097/MD.0000000000030021\nLiu, S., Chang, X., Yu, J., Xu, W ., 2020. Cerasus humilis Cherry\nPolyphenol Reduces High-Fat Diet-Induced Obesity in C57BL/6\nMice by Mitigating Fat Deposition, Inflammation, and Oxidation.\nJournal of Agricultural and Food Chemistry. 68, 4424–4436. https://\ndoi.org/10.1021/acs.jafc.0c01617\nLodhi, S., Kori, M.L., 2021. Structure - Activity Relationship and\nTherapeutic Benefits of Flavonoids in the Management of Diabetes\nand Associated Disorders. Pharmaceutical Chemistry Journal. 54,\n1106–1125. https://doi.org/10.1007/s11094-021-02329-9\nMahady, G.B., Doyle, B., Locklear, T ., Cotler, S.J., Guzman-Hartman, G.,\nKrishnaraj, R., 2006. Black cohosh efficacy and safety for menopausal\nsymptoms. The Spanish Menopause Society statement. Gynecological\nEndocrinology. 38, 379–384. https://doi.org/10.1080/09513590\n.2022.2056591\nMan, G.C.W ., Xu, H., Chiu, C., 2012. Green T ea for Endometriosis.\nEndometriosis - Basic Concepts and Current Research T rends,\n276–296. http://www.intechopen.com/books/endometriosis-basic\n-concepts-and-current-research-trends/green-tea-for-endometriosis\n10.5772/28874\nMatsuzaki, S., Darcha, C., 2015. Co-operation between the AKT and\nERK signaling pathways may support growth of deep endometriosis\nin a fibrotic microenvironment in vitro. Human Reproduction. 30,\n1607–1617. https://doi.org/10.1093/humrep/dev108\nMaulitz, L., Stickeler, E., Stickel, S., Habel, U., Tchaikovski, S.N.,\nChechko, N., 2022. Endometriosis, psychiatric comorbidities and\nneuroimaging: Estimating the odds of an endometriosis brain.\nFrontiers in Neuroendocrinology. 65, 100988. https://doi.org/10\nN a t u r a l R e s o u r c e s f o r H u m a n H e a l t h 2024, 4, 75–88 | 86\n\nEkbbal et al View Article Online\n.1016/j.yfrne.2022.100988\nMayo, J.L., 1998. Black Cohosh and Chasteberry: Herbs Valued by\nWomen for Centuries. Clinical Nutrition Insights. 6, 1–4.\nMinnetti, M., De Alcubierre, D., Bonaventura, I., Pofi, R., Hasenma-\njer, V ., T arsitano, M.G., Gianfrilli, D., Poggiogalle, E., Isidori, A.M.,\n2022. Effects of licorice on sex hormones and the reproductive\nsystem. Nutrition. 103-104, 111727. https://doi.org/10.1016/j.nut\n.2022.111727\nMistry, M., Simpson, P ., Morris, E., Fritz, A.K., Karavadra, B., Lennox, C.,\nProsser-Snelling, E., 2022. Cannabidiol for the Management of\nEndometriosis and Chronic Pelvic Pain. Journal of Minimally Invasive\nGynecology. 29, 169–176. https://doi.org/10.1016/j.jmig.2021.11\n.017\nMitkowski, N.A., Abawi, G.S., 2002. Monoxenic maintenance and\nreproduction of root-knot nematode (Meloidogyne hapla) on multiple-\nspecies in vitro root culture systems. Plant Cell Reports. 21, 14–23.\nhttps://doi.org/10.1007/s00299-002-0468-6\nMiyashita, M., Koga, K., Izumi, G., Sue, F ., Makabe, T ., T aguchi, A.,\nNagai, M., Urata, Y., T akamura, M., Harada, M., Hirata, T .,\nHirota, Y., Wada-Hiraike, O., Fujii, T ., Osuga, Y., 2016. Effects of\n1,25-Dihydroxy vitamin d3 on endometriosis. Journal of Clinical\nEndocrinology and Metabolism. 101, 2371–2379. https://doi.org/\n10.1210/jc.2016-1515\nMollazadeh, S., Mirghafourvand, M., Abdollahi, N.G., 2020. The effects\nof Vitex agnus-castus on menstrual bleeding: A systematic review and\nmeta-analysis. Journal of Complementary and Integrative Medicine.\n17, 20180053. https://doi.org/10.1515/jcim-2018-0053\nNathiya, S., Durga, M., Devasena, T ., 2014. Quercetin, encapsulated\nquercetin and its application- A review. International Journal of\nPharmacy and Pharmaceutical Sciences. 6, 1–7.\nNCT04527003., 2020. Cannabidiol and Management of Endometriosis\nPain. https://clinicaltrials.gov/show/NCT04527003\nNishteswar, K., 2013. Pharmacological expression of Rasayanakarma. Ayu.\n34, 337–338.\nOgaly, H.A., Alsherbiny, M.A., Badawy, S.A., Abd-Elsalam, R.M.,\nLi, C., Azouz, A.A., 2021. Gastroprotective effects and metabolomic\nprofiling of Chasteberry fruits against indomethacin-induced gastric\ninjury in rats. Journal of Functional Foods. 86, 104732. https://\ndoi.org/10.1016/j.jff.2021.104732\nOkimura, H., T atsumi, H., Ito, F ., Yamashita, S., Kokabu, T .,\nKitawaki, J., 2018. Endometrioid carcinoma arising from diaphrag-\nmatic endometriosis treated with laparoscopy: A case report. Journal\nof Obstetrics and Gynaecology Research. 44, 972–977. https://doi\n.org/10.1111/jog.13595\nOta, Y., Ota, K., T akahashi, T ., Suzki, S., Sano, R., Ota, I., Moriya, T .,\nShiota, M., 2020. Primary endometrioid carcinoma of the uterosacral\nligament arising from deep infiltrating endometriosis 6 years\nafter bilateral salpingo-oophorectomy due to atypical proliferative\nendometrioid tumor of the ovary: a rare case report. World Journal\nof Surgical Oncology. 18, 329. https://doi.org/10.1186/s12957-020\n-02105-1\nParkhe, G., Bharti, D., 2019. Phytochemical investigation and determi-\nnation of total phenols and flavonoid concentration in leaves extract\nof Vitex trifolia linn. Journal of Drug Delivery and Therapeutics. 9,\n705–707. https://doi.org/10.22270/jddt.v9i4-A.3554\nPrilepskaya, V .N., Dovletkhanova, E.R., 2020. Premenstrual syndrome:\nclinical management of patients in the outpatient practice. Reproduc-\ntive Endocrinology. 12, 30–34. https://doi.org/10.18370/2309-4117\n.2013.12.30-34\nQi, X., Yun, C., Pang, Y., Qiao, J., 2021. The impact of the gut microbiota\non the reproductive and metabolic endocrine system. Gut Microbes.\n13, 1894070. https://doi.org/10.1080/19490976.2021.1894070\nR, R.B., A, K., S, S., A, G.F ., Gunalan., 2019. Potential natural products\nwith anticancer properties and their applications. Asian Journal of\nPharmaceutical and Clinical Research. 12, 27–33. https://doi.org/\n10.22159/ajpcr.2019.v12i5.32817\nRahmani, A.H., Anwar, S., Raut, R., Almatroudi, A., Babiker, A.Y.,\nKhan, A.A., Alsahli, M.A., Almatroodi, S.A., 2022. Therapeutic\nPotential of Myrrh, a Natural Resin, in Health Management through\nModulation of Oxidative Stress, Inflammation, and Advanced\nGlycation End Products Formation Using In Vitro and In Silico\nAnalysis. Applied Sciences. 12, 9175. https://doi.org/10.3390/\napp12189175\nRbr-6ryrpjs., 2021. https://trialsearch.who.int/Trial2.aspx?TrialID=RBR\n-6ryrpjs\nRiggi, L.G.A., Lundin, O., Berggren, Å., 2021. Mass-flowering red clover\ncrops have positive effects on bumblebee richness and diversity after\nbloom. Basic and Applied Ecology. 56, 21–31. https://doi.org/10\n.1016/j.baae.2021.06.001\nSaha, S.K., Khuda-Bukhsh, A.R., 2015. Berberine alters epigenetic\nmodifications, disrupts microtubule network, and modulates HPV-18\nE6-E7 oncoproteins by targeting p53 in cervical cancer cell HeLa: A\nmechanistic study including molecular docking. European Journal of\nPharmacology. 744, 132–146. https://doi.org/10.1016/j.ejphar.2014\n.09.048\nSalari, S., Amiri, M.S., Ramezani, M., Moghadam, A.T ., Elyasi, S.,\nSahebkar, A., Emami, S.A., 2021. Ethnobotany, Phytochemistry,\nT raditional and Modern Uses of Actaea racemosa L. (Black cohosh):\nA Review. Advances in Experimental Medicine and Biology. 1308,\n403–449. https://doi.org/10.1007/978-3-030-64872-5_24\nSankar, G., 2018. Integrative Approach to Infertility- Does the Society\nallow them? Indian J. Physiol. Pharmacol.\nSaptarini, N., Rahayu, D., Herawati, I., 2019. Antioxidant activity\nof crude bromelain of pineapple ( Ananas comosus (L.) Merr)\ncrown from Subang district, Indonesia. Journal of Pharmacy and\nBioallied Sciences. 11, S551–S555. https://doi.org/10.4103/jpbs.jpbs\n_200_19\nScheerer, C., Bauer, P ., Chiantera, V ., Sehouli, J., Kaufmann, A., Mech-\nsner, S., 2016. Characterization of endometriosis-associated immune\ncell infiltrates (EMaICI). Archives of Gynecology and Obstetrics. 294,\n657–664. https://doi.org/10.1007/s00404-016-4142-6\nSeidlova-Wuttke, D., Wuttke, W ., 2019. The premenstrual syndrome,\npremenstrual mastodynia, fibrocystic mastopathy and infertility have\noften common roots effects of extracts of chasteberry ( Vitex agnus -\ncastus) as a solution. Clinical Phytoscience. 3, 6. https://doi.org/\n10.1186/s40816-016-0038-z\nSelak, V ., Farquhar, C., Prentice, A., Singla, A., 2007. Danazol\nfor pelvic pain associated with endometriosis. Cochrane Database\nof Systematic Reviews. 2000, CD000068. https://doi.org/10.1002/\n14651858.cd000068\nSeo, M.J., Lee, Y.J., Hwang, J.H., Kim, K.J., Lee, B.Y., 2015.\nThe inhibitory effects of quercetin on obesity and obesity-induced\ninflammation by regulation of MAPK signaling. The Journal of\nNutritional Biochemistry. 26, 1308–1316. https://doi.org/10.1016/\nj.jnutbio.2015.06.005\nSheikholeslami, A., Kalhor, N., Sheykhhasan, M., Jannatifar, R.,\nSahraei, S.S., 2021. Evaluating differentiation potential of the human\nmenstrual blood-derived stem cells from infertile women into oocyte-\nlike cells. Reproductive Biology. 21, 100477. https://doi.org/10\n.1016/j.repbio.2020.100477\nSingh, S.S., Evans, D., Mcdonald, S., Senterman, M., Strickland, S.,\n2020. Ulipristal Acetate Prior to Surgery for Endometriosis. Repro-\nductive Sciences. 27, 1707–1714. https://doi.org/10.1007/s43032\n-020-00146-1\nN a t u r a l R e s o u r c e s f o r H u m a n H e a l t h 2024, 4, 75–88 | 87\n\nEkbbal et al View Article Online\nSmith, E.R., Huang, M., Schlumbrecht, M.P ., George, S.H.L., Xu, X.X.,\n2022. Rationale for combination of paclitaxel and CDK4/6 inhibitor\nin ovarian cancer therapy - non-mitotic mechanisms of paclitaxel.\nFront. Oncol.\nSmolarz, B., Szyłło, K., Romanowicz, H., 2021. Endometriosis:\nEpidemiology, classification, pathogenesis, treatment and genetics\n(review of literature). International Journal of Molecular Sciences. 22,\n10554. https://doi.org/10.3390/ijms221910554\nStewart, K., Deb, S., 2016. Dysmenorrhoea. Obstetrics, Gynaecology\nand Reproductive Medicine. 29, 286–291. https://doi.org/10.1016/\nj.ogrm.2019.06.002\nStute, P ., Bodmer, C., Ehler, U., Eltbogen, R., Ging, A., Streuli, I.,\nWolff, M.V ., 2019. Interdisciplinary consensus on management of\npremenstrual disorders in Switzerland. Gynecological Endocrinology.\n33, 342–348. https://doi.org/10.1080/09513590.2017.1284788\nSuliman, R.S., Alghamdi, S.S., Ali, R., Aljatli, D., Aljammaz, N.A.,\nHuwaizi, S., Suliman, R., Kahtani, K.M., Albadrani, G.M.,\nBarhoumi, T ., Altolayyan, A., Rahman, I., 2022. The Role of\nMyrrh Metabolites in Cancer, Inflammation, and Wound Healing:\nProspects for a Multi-T argeted Drug Therapy. Pharmaceuticals. 15,\n944. https://doi.org/10.3390/ph15080944 https://doi.org/10.3390/\nph15080944\nSzałabska-Rąpała, K., Borymska, W ., Kaczmarczyk-Sedlak, I., 2021.\nEffectiveness of magnolol, a lignan from magnolia bark, in dia-\nbetes, its complications and comorbidities-A review. International\nJournal of Molecular Sciences. 23, 7765. https://doi.org/10.3390/\nijms23147765\nT ucci, C., Feliciantonio, M.D., V ena, F ., Capone, C., Schiavi, M.C.,\nPietrangeli, D., Muzii, L., Panici, P .B., 2018. Alpha lipoic acid in\nobstetrics and gynecology. Gynecological Endocrinology. 34, 729–\n733. https://doi.org/10.1080/09513590.2018.1462320\nVallée, A., Lecarpentier, Y., 2020. Curcumin and endometriosis.\nInternational Journal of Molecular Sciences. 21, 2440. https://doi\n.org/10.3390/ijms21072440\nVan Die, M.D., Burger, H., T eede, H., Bone, K., 2013.Vitex agnus-castus\nextracts for female reproductive disorders: A systematic review of\nclinical trials. Planta Medica. 79, 562–575. https://doi.org/10.1055/\ns-0032-1327831\nVan Steenwijk, H.P ., Bast, A., De Boer, A., 2020. The Role of Circulating\nLycopene in Low-Grade Chronic Inflammation: A Systematic Review\nof the Literature. Molecules. 25, 4378. https://doi.org/10.3390/\nmolecules25194378\nV ercellini, P ., Buggio, L., Berlanda, N., Barbara, G., Somigliana, E.,\nBosari, S., 2016. Estrogen-progestins and progestins for the man-\nagement of endometriosis. Fertility and Sterility. 106, 552-1571.e2.\nhttps://doi.org/10.1016/j.fertnstert.2016.10.022\nWarowicka, A., Qasem, B., Dera-Szymanowska, A., Wołuń-Cholewa, M.,\nFlorczak, P ., Horst, N., Napierała, M., Szymanowski, K., Popenda, Ł.,\nBartkowiak, G., Florek, E., Goździcka-Józefiak, A., Młynarz, P .,\n2021. Effect of Protoberberine-Rich Fraction of Chelidonium\nmajus L. on Endometriosis Regression. Pharmaceutics. 13, 931.\nhttps://doi.org/10.3390/pharmaceutics13070931 https://doi.org/10\n.3390/pharmaceutics13070931\nWee, H.N., Neo, S.Y., Singh, D., Yew, H.C., Qiu, Z.Y., T sai, X.R.C.,\nHow, S.Y., Yip, K.Y.C., T an, C.H., Koh, H.L., 2020. Effects of Vitex\ntrifolia L. Leaf extracts and phytoconstituents on cytokine production\nin human u937 macrophages. BMC Complementary Medicine and\nTherapies. 20, 91. https://doi.org/10.1186/s12906-020-02884-w\nWhitaker, L.H.R., Williams, A.R.W ., Critchley, H.O.D., 2014.\nSelective progesterone receptor modulators. Current Opinion in\nObstetrics and Gynecology. 26, 237–242. https://doi.org/10.1097/\ngco.0000000000000082\nWright, S., Valdes, C.T ., Dunn, R.C., Franklin, R.R., 1995. Short-\nterm lupron or danazol therapy for pelvic endometriosis. Fertility and\nSterility. 63, 504–507.\nXiao, Y.H., Chen, D.P ., Yan, J.H., Yokoyama, Y., 2002. Mechanism\nof action of T ripterygium wilfordii polyglycoside on experimental\nendometriosis. European Journal of Gynaecological Oncology. 23,\n63–67.\nXu, Y., Li, L., 2018. Primary squamous cell carcinoma arising from\nendometriosis of the ovary: A case report and literature review.\nCurrent Problems in Cancer. 42, 329–336. https://doi.org/10.1016/\nj.currproblcancer.2018.02.001\nYee, E.M.H., Pasquier, E., Iskander, G., Wood, K., Black, D.S.,\nKumar, N., 2013. Synthesis of novel isoflavene-propranolol hybrids\nas anti-tumor agents. Bioorganic & Medicinal Chemistry. 21, 1652–\n1660. https://doi.org/10.1016/j.bmc.2013.01.059\nZahiruddin, S., Parveen, A., Khan, W ., Parveen, R., Ahmad, S., 2021.\nTLC-Based Metabolite Profiling and Bioactivity-Based Scientific\nValidation for Use of Water Extracts in AYUSH Formulations.\nEvidence-Based Complementary and Alternative Medicine. 2021,\n2847440. https://doi.org/10.1155/2021/2847440\nZhang, W ., Xu, J.H., Yu, T ., Chen, Q.K., 2019. Effects of berberine\nand metformin on intestinal inflammation and gut microbiome\ncomposition in db/db mice. Biomedicine & Pharmacotherapy. 118,\n109131. https://doi.org/10.1016/j.biopha.2019.109131\nZhou, J.Y., Zhou, S.W ., 2011. Protective effect of berberine on antioxidant\nenzymes and positive transcription elongation factor b expression in\ndiabetic rat liver. Fitoterapia. 82, 184–189. https://doi.org/10.1016/\nj.fitote.2010.08.019\nN a t u r a l R e s o u r c e s f o r H u m a n H e a l t h 2024, 4, 75–88 | 88","source_license":"CC0","license_restricted":false}